Corvus Pharmaceuticals, Inc.
CRVS
Revenue
0.00
0.000.00%
-Assets
89.46M
▲30.02M▲50.51%
3 Months ChangeLiabilities
9.23M
▼-880.00k▼-8.70%
3 Months ChangeFree Cash Flow
-8.30M
▼-154.00k▼-1.89%
24 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-23
Form 8-K
ID: 0001558370-24-013518
2024-08-06
Form 10-Q
ID: 0001558370-24-011076
2024-08-06
Form 8-K
ID: 0001171843-24-004479
2024-06-14
Form 8-K
ID: 0001171843-24-003444
2024-05-07
Form 10-Q
ID: 0001558370-24-007093
2024-05-06
Form 8-K
ID: 0001193125-24-131920
2024-05-06
Form 8-K
ID: 0001171843-24-002569
2024-05-01
Form 8-K
ID: 0001193125-24-127611
2024-03-19
Form 8-K
ID: 0001171843-24-001454
2024-01-23
Form 8-K
ID: 0001171843-24-000360